Difficulty: Medium
Average Score: 92%
Practice
An 83-year-old woman with Parkinson's disease is currently being treated with carbidopa/levodopa, but her Parkinson's symptoms are worsening. She has normal liver function and no history of liver disease. The physician adds tolcapone to her regimen on tolcapone. How does tolcapone help in Parkinson's disease?
Correct answer
B
Rationale
In the treatment of Parkinson's disease, carbidopa/levodopa is commonly used to increase dopamine levels in the brain. However, levodopa is metabolized by catechol-O-methyltransferase (COMT) in the peripheral tissues, leading to reduced availability of levodopa in the brain. Tolcapone is a COMT inhibitor that helps prolong the effects of levodopa by inhibiting its peripheral metabolism. This results in higher levels of levodopa reaching the brain, leading to improved motor function in patients with Parkinson's disease.
Option A, increased norepinephrine synthesis, is incorrect because tolcapone does not directly affect norepinephrine synthesis. Option C, inhibition of MAO, is incorrect because MAO inhibitors are a different class of drugs used in Parkinson's disease treatment. Option D, stimulation of acetylcholine release, is incorrect because tolcapone does not act on acetylcholine release.
In an educational context, understanding the mechanisms of action of different drugs used in the treatment of Parkinson's disease is crucial for nurses and healthcare professionals to provide safe and effective care to patients. Knowing how tolcapone works as a COMT inhibitor can guide healthcare providers in optimizing drug therapy for patients with Parkinson's disease, ultimately improving patient outcomes.
Option A, increased norepinephrine synthesis, is incorrect because tolcapone does not directly affect norepinephrine synthesis. Option C, inhibition of MAO, is incorrect because MAO inhibitors are a different class of drugs used in Parkinson's disease treatment. Option D, stimulation of acetylcholine release, is incorrect because tolcapone does not act on acetylcholine release.
In an educational context, understanding the mechanisms of action of different drugs used in the treatment of Parkinson's disease is crucial for nurses and healthcare professionals to provide safe and effective care to patients. Knowing how tolcapone works as a COMT inhibitor can guide healthcare providers in optimizing drug therapy for patients with Parkinson's disease, ultimately improving patient outcomes.